Skip to content
Back to Feed
Seed

Cosi Care secures $1m from 43North to fund expansion into the United States.

The UK healthtech firm won the funding as part of the 43North startup competition and the People's Choice Award.

$1.0MSeed

Cosi Care designs medical devices that deliver cooling and soothing sensations for chronic skin conditions such as eczema. The company serves over 50,000 customers in the UK.

Cosi Care has secured $1m in funding after being named one of five winners in the 43North startup competition based in Buffalo, New York. The brand also claimed an additional $25k through the public vote for the People's Choice Award.

Founded in 2018, the healthtech firm developed a medical device providing instant relief for eczema and other skin irritations. The capital will support the company's expansion into the United States market as it seeks to scale its operations globally.

While pushing into North America, Cosi Care confirmed that parts of its supply chain and product development will remain based in the UK alongside planned hiring activity.


From the founder

"We are so proud to have received the recent funding from 43North, and to have also been recognised by the Buffalo community for the People's Choice Award."
LB

Lauren Bell

Co-founder at Cosi Care


Use of funds

  1. 01Expand into international markets
  2. 02Grow the team

Investors

43North

43North


Categories

HardwareHealthTechMedTechWearables

About the company

CC

Cosi Care

Cosi Care manufactures safe medical devices designed to provide instant itch relief for skin conditions.

United Kingdom Founded 2018
$1.0MRaised